CNS Summit 2022
100% Dedicated to the Art and Science of CNS Drug Discovery
We know that no other area of medical research requires as much rigor and inventiveness as CNS Clinical Development.
Our team of nearly 1,600 experts is the first and only fully dedicated CNS business unit in the CRO world, robustly resourced to support your CNS drug development success, no matter how big or small your organization. Our CNS-experienced clinical leaders will provide you with deep therapeutic knowledge, hands-on trial experience, financial understanding and strong leadership and partnering skills, on every step of your CNS journey.
Be sure to find us on the floor at CNS Summit 2022, at booth #52
FEATURED PANEL:
Fireside Chat
Michelle Keefe
CEO, Syneos Health
Friday November 18 | Time: TBD
Want to learn more? Explore Insights Hub
or click on the resources below:
Neuroscience: Accelerate Your Drug Development Success to Patients in Need
Cell and Gene Therapy Consortium Fact Sheet
Syneos Health Podcast: Opportunities and Challenges in Cell and Gene Therapy
Designing Gene Therapy Study Protocols Based on Patient Burden Scores
Syneos Health Podcast: The Placebo Effect
Challenges and Opportunities in Epilepsy Clinical Trials
Advanced Therapy Medicinal Product (ATMP) Clinical Trials: Navigating Recent Scientific and Regulatory Rules of the Road in the US and EU
